Patents by Inventor Miodrag Ristic

Miodrag Ristic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5855902
    Abstract: A subunit vaccine for Tritrichomonas foetus and method for preparing such vaccine for use in immunizing and treating animals is provided. The method disclosed involves separating out the antigens by centrifuging homogenized Tritrichomonas foetus cells, preferably at about 830.times.g for about 15 minutes, solubilizing the antigen with an nonionic detergent and completing with saponin. Topical administration, such as intravaginal or intrapretutial administration, of such vaccine preparation in conjunction with subcutaneous administration in combination with other adjuvants is effective to eliminate infection.
    Type: Grant
    Filed: February 7, 1994
    Date of Patent: January 5, 1999
    Assignee: Protatek International, Inc.
    Inventors: Miodrag Ristic, Lionel Wanduragala
  • Patent number: 4767622
    Abstract: Disclosed are vaccine compositions for use in developing protective immunity against infection by Plasmodium parasites. Soluble proteinaceous immunogens are isolated from the fluid culture medium of in vitro propagated plasmodial species parasites (e.g., P.falciparum) in mammalian erythrocyte culture supernatant or from washes, including hypotonic washes, of cultured erythrocytes parasitized by plasmodium. Immunogens so obtained have molecular weights in the range from about 35,000 daltons to about 85,000 daltons. Two principal immunogens of the invention have molecular weights of about 42,000 and 54,000 daltons, respectively. The water soluble immunogens are administered in a suitable carrier such as isotonic salt solution and in combination with a suitable adjuvant such as saponin or, preferably, aluminum hydroxide.
    Type: Grant
    Filed: August 19, 1983
    Date of Patent: August 30, 1988
    Assignee: University of Illinois
    Inventors: Miodrag Ristic, Mary L. Chilbert
  • Patent number: 4596707
    Abstract: Soluble antigen, specific for Babesia parasites, is isolated from growth media of Babesia-infected erythrocytes in cell culture and characterized, inter alia, by its ability to inhibit the capacity of specific Babesia serum antibodies to neutralize infectivity of Babesia merozoites in vitro. Antigen preparations provide immunologically active components useful for vaccination of animals against infection by Babesia parasites and may be employed in the preparation of diagnostic reagents.
    Type: Grant
    Filed: March 31, 1980
    Date of Patent: June 24, 1986
    Assignee: University of Illinois Foundation
    Inventors: Miodrag Ristic, Carlos Arellano
  • Patent number: 4307191
    Abstract: A method for quantitative propagation of hemotropic parasites, especially Babesia parasites, in vitro, Babesia-infected erythrocyte cultures are incubated in an environment of enhanced carbon dioxide tension wherein the culture medium overlay provides a barrier to oxygen transmission such that cellular hemoglobin is essentially maintained in its deoxy state. By varying environmental carbon dioxide tension, merozoite stages of the parasite are selectively reversibly induced to migration between residence in host cells or culture medium, rendering possible the isolation of infective antigenic merozoites in large quantities. Specific Babesia antigen is harvested in large quantity from the in vitro culture medium.
    Type: Grant
    Filed: March 31, 1980
    Date of Patent: December 22, 1981
    Assignee: University of Illinois Foundation
    Inventors: Miodrag Ristic, Michael G. Levy